|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
This article has been cited by other articles:
![]() |
K. G.N. Suzuki, T. K. Fujiwara, F. Sanematsu, R. Iino, M. Edidin, and A. Kusumi GPI-anchored receptor clusters transiently recruit Lyn and G{alpha} for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1 J. Cell Biol., May 21, 2007; 177(4): 717 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G.N. Suzuki, T. K. Fujiwara, M. Edidin, and A. Kusumi Dynamic recruitment of phospholipase C{gamma} at transiently immobilized GPI-anchored receptor clusters induces IP3-Ca2+ signaling: single-molecule tracking study 2 J. Cell Biol., May 21, 2007; 177(4): 731 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Macor, D. Mezzanzanica, C. Cossetti, P. Alberti, M. Figini, S. Canevari, and F. Tedesco Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma. Cancer Res., April 1, 2006; 66(7): 3876 - 3883. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miotti, A. Tomassetti, I. Facetti, E. Sanna, V. Berno, and S. Canevari Simultaneous Expression of Caveolin-1 and E-Cadherin in Ovarian Carcinoma Cells Stabilizes Adherens Junctions through Inhibition of src-Related Kinases Am. J. Pathol., November 1, 2005; 167(5): 1411 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Kelemen, T. A. Sellers, G. L. Keeney, and W. L. Lingle Multivitamin and Alcohol Intake and Folate Receptor {alpha} Expression in Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2168 - 2172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Jhaveri, A. S. Rait, K.-N. Chung, J. B. Trepel, and E. H. Chang Antisense oligonucleotides targeted to the human {alpha} folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatment Mol. Cancer Ther., December 1, 2004; 3(12): 1505 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.G. Kim and J.L. Vallet Secreted and Placental Membrane Forms of Folate-Binding Protein Occur Sequentially During Pregnancy in Swine Biol Reprod, October 1, 2004; 71(4): 1214 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Elenko, T. Fischer, I. Niesman, T. Harding, T. McQuistan, M. Von Zastrow, and M. G. Farquhar Spatial Regulation of G{alpha}i Protein Signaling in Clathrin-Coated Membrane Microdomains Containing GAIP Mol. Pharmacol., July 1, 2003; 64(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Theti, V. Bavetsias, L. A. Skelton, J. Titley, D. Gibbs, G. Jansen, and A. L. Jackman Selective Delivery of CB300638, a Cyclopenta[g]quinazoline-based Thymidylate Synthase Inhibitor into Human Tumor Cell Lines Overexpressing the {alpha}-Isoform of the Folate Receptor Cancer Res., July 1, 2003; 63(13): 3612 - 3618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tomassetti, F. Mangiarotti, M. Mazzi, S. Sforzini, S. Miotti, E. Galmozzi, P. C. Elwood, and S. Canevari The Variant Hepatocyte Nuclear Factor 1 Activates the P1 Promoter of the Human {alpha}-Folate Receptor Gene in Ovarian Carcinoma Cancer Res., February 1, 2003; 63(3): 696 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wong, S. Uddin, B. Majchrzak, T. Huynh, A. E. I. Proudfoot, L. C. Platanias, and E. N. Fish RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells J. Biol. Chem., March 30, 2001; 276(14): 11427 - 11431. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||